JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB85529

Anti-HIV1 Rev antibody [Rev-6]

4

(1 Review)

|

(9 Publications)

Mouse Recombinant Monoclonal REV antibody. Suitable for WB, ELISA, ICC/IF and reacts with Transfected cell line - Human immunodeficiency virus, Recombinant full length protein - Human immunodeficiency virus samples. Cited in 9 publications.

View Alternative Names

Protein Rev, ART/TRS, Anti-repression transactivator, Regulator of expression of viral proteins, rev

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-HIV1 Rev antibody [Rev-6] (AB85529)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-HIV1 Rev antibody [Rev-6] (AB85529)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized 293T cells transfected with a HIV1 Rev M, HIV Rev N, a HIV1 Rev O and HIV2 Rev expression vector labelling HIV Rev with ab85529 at 1/500 dilution. ab85529 was incubated overnight at 4° C, followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (ab150117) at 1/1000 dilution at RT for 45 min. ab9106 Anti-Myc Rabbit polyclonal antibody at 1/200 dilution, was co-incubated with ab85529 overnight at 4° C. Nucleus were visualized using DAPI.

Confocal image showing positive staining in 293T cells transfected with a HIV1 Rev M and HIV Rev N expression vector containing a myc-His-tag®(shown in green). but no staining in 293T cells transfected with a HIV1 Rev O and HIV2 Rev expression vector containing a myc-His-tag®.

Western blot - Anti-HIV1 Rev antibody [Rev-6] (AB85529)
  • WB

PubMed

Western blot - Anti-HIV1 Rev antibody [Rev-6] (AB85529)

Representative western blot detecting HIV1 Rev using ab85529 at 1/250 dilution. An HRP-conjugated secondary antibody (1/5000) was used.

HeLa cells stably transduced with an inducible Tet-On HIV-1 system, were untreated or treated for 4-5 h with TG009 or chlorhexidine, followed by induction of expression of the endogenous HIV-1 provirus by addition of doxycycline. Please note this image was from a different batch produced using hybridoma method

All lanes:

Western blot - Anti-HIV1 Rev antibody [Rev-6] (ab85529)

Predicted band size: 13 kDa

false

Image from Wong R et al., Retrovirology. 2011 Jun 17;8:47.Fig 8.; doi:10.1186/1742-4690-8-47; 17 June, 2011, Retrovirology, 8:47

Indirect ELISA - Anti-HIV1 Rev antibody [Rev-6] (AB85529)
  • I-ELISA

Lab

Indirect ELISA - Anti-HIV1 Rev antibody [Rev-6] (AB85529)

Indirect ELISA analysis of ab133468 incubated with HIV-1 rev recombinant protein for 60 minutes. The Secondary antibody used was Goat Anti-Rabbit IgG (H+L), alkaline phosphatase-conjugated at 1/1000 dilution dilution.

OD was read at 405nm within 5 minutes.

Western blot - Anti-HIV1 Rev antibody [Rev-6] (AB85529)
  • WB

Lab

Western blot - Anti-HIV1 Rev antibody [Rev-6] (AB85529)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-HIV1 Rev antibody [Rev-6] (ab85529) at 1/1000 dilution

Lane 1:

293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a myc-his-tag, whole cell lysate at 20 µg

Lane 2:

293T cells transfected with HIV1 group M Rev containing a myc-his-tag, whole cell lysate at 20 µg

Secondary

All lanes:

Peroxidase-Conjugated Goat anti-Mouse IgG (H+L)

Observed band size: 22 kDa

true

Exposure time: 180s

  • Carrier free

    Anti-HIV1 Rev antibody [Rev-6] - BSA and Azide free

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

Rev-6

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human immunodeficiency virus

Applications

ELISA, WB, ICC/IF

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human immunodeficiency virus": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ELISA-species-checked": "predicted", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Recombinant full length protein - Human immunodeficiency virus": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Transfected cell line - Human immunodeficiency virus": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ELISA-species-checked": "notRecommended", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>" } } }

Product details

The production method has been switched from hybridoma to recombinant on 06th June 2025.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Purified from supernatants of hybridoma cell cultures by affinity chromatography based on Protein A.
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The HIV-1 Rev protein also known as Regulatory protein Rev is an essential component of the HIV-1 virus. It weighs approximately 13 kDa and plays an important role in the viral replication cycle. HIV-1 Rev is expressed in cells infected by the HIV-1 virus predominantly within the nucleus. It interacts with viral RNA elements known as the Rev Response Elements (RRE) helping in the regulation of viral mRNA during the HIV-1 life cycle. Researchers often use techniques like Western blotting to detect and study this protein due to its significant role in HIV infection.
Biological function summary

The Rev protein facilitates a critical stage in the gene expression of HIV in infected cells. It aids in the export of intron-containing viral RNA from the nucleus to the cytoplasm ensuring that these RNAs are effectively translated into viral proteins. HIV-1 Rev does not function alone; it forms part of a complex involving other cellular proteins such as exportin-1 (CRM1) that helps in its transport functions. This complex interaction allows the virus to efficiently reproduce by bypassing the normal cellular restrictions on nuclear export.

Pathways

The HIV-1 Rev protein interacts with pathways involved in viral mRNA transport and gene expression regulation. It is particularly significant in the CRM1-mediated nuclear export pathway. Through this pathway Rev is related to various proteins such as Ran GTPase which is critical for the nucleocytoplasmic transport mechanisms. These pathways are vital for the replication and assembly of new viral particles within HIV-infected cells.

The HIV-1 Rev protein is a central figure in the progression of HIV/AIDS. It controls the expression of viral genes impacting how rapidly and effectively the virus multiplies. In the context of HIV-related diseases Rev influences proteins involved in the host cell's regulatory systems including the p53 tumor suppressor protein which can affect cell cycle and apoptosis. Understanding Rev's function and interactions is important in developing treatments that target and mitigate the progression of HIV/AIDS.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Escorts unspliced or incompletely spliced viral pre-mRNAs (late transcripts) out of the nucleus of infected cells. These pre-mRNAs carry a recognition sequence called Rev responsive element (RRE) located in the env gene, that is not present in fully spliced viral mRNAs (early transcripts). This function is essential since most viral proteins are translated from unspliced or partially spliced pre-mRNAs which cannot exit the nucleus by the pathway used by fully processed cellular mRNAs. Rev itself is translated from a fully spliced mRNA that readily exits the nucleus. Rev's nuclear localization signal (NLS) binds directly to KPNB1/Importin beta-1 without previous binding to KPNA1/Importin alpha-1. KPNB1 binds to the GDP bound form of RAN (Ran-GDP) and targets Rev to the nucleus. In the nucleus, the conversion from Ran-GDP to Ran-GTP dissociates Rev from KPNB1 and allows Rev's binding to the RRE in viral pre-mRNAs. Rev multimerization on the RRE via cooperative assembly exposes its nuclear export signal (NES) to the surface. Rev can then form a complex with XPO1/CRM1 and Ran-GTP, leading to nuclear export of the complex. Conversion from Ran-GTP to Ran-GDP mediates dissociation of the Rev/RRE/XPO1/RAN complex, so that Rev can return to the nucleus for a subsequent round of export. Beside KPNB1, also seems to interact with TNPO1/Transportin-1, RANBP5/IPO5 and IPO7/RANBP7 for nuclear import. The nucleoporin-like HRB/RIP is an essential cofactor that probably indirectly interacts with Rev to release HIV RNAs from the perinuclear region to the cytoplasm.
See full target information rev

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Molecular therapy. Methods & clinical development 29:40-57 PubMed36936448

2023

Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning.

Applications

Unspecified application

Species

Unspecified reactive species

Sophie Broussau,Viktoria Lytvyn,Mélanie Simoneau,Claire Guilbault,Mélanie Leclerc,Nazila Nazemi-Moghaddam,Nathalie Coulombe,Seyyed Mehdy Elahi,Scott McComb,Rénald Gilbert

Journal of virology 93: PubMed30651369

2019

The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.

Applications

Unspecified application

Species

Unspecified reactive species

Wuxun Lu,Shuliang Chen,Jingyou Yu,Ryan Behrens,Joshua Wiggins,Nathan Sherer,Shan-Lu Liu,Yong Xiong,Shi-Hua Xiang,Li Wu

mBio 9: PubMed30401776

2018

Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.

Applications

Unspecified application

Species

Unspecified reactive species

George B Kyei,Shanshan Meng,Rashmi Ramani,Austin Niu,Chandraiah Lagisetti,Thomas R Webb,Lee Ratner

Journal of virology 91: PubMed27852860

2017

Nuclear Export Signal Masking Regulates HIV-1 Rev Trafficking and Viral RNA Nuclear Export.

Applications

Unspecified application

Species

Unspecified reactive species

Ryan T Behrens,Mounavya Aligeti,Ginger M Pocock,Christina A Higgins,Nathan M Sherer

Methods in molecular biology (Clifton, N.J.) 1087:103-14 PubMed24158817

2013

HIV-1 Rev function and RNA nuclear-cytoplasmic export.

Applications

Unspecified application

Species

Unspecified reactive species

Alan Cochrane

Nucleic acids research 41:9471-83 PubMed23945945

2013

Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.

Applications

Unspecified application

Species

Human

Raymond W Wong,Ahalya Balachandran,Matthew Haaland,Peter Stoilov,Alan Cochrane

PLoS pathogens 9:e1003241 PubMed23555254

2013

Digoxin suppresses HIV-1 replication by altering viral RNA processing.

Applications

WB

Species

Unspecified reactive species

Raymond W Wong,Ahalya Balachandran,Mario A Ostrowski,Alan Cochrane

Nucleic acids research 40:3663-75 PubMed22187150

2011

Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression.

Applications

WB

Species

Unspecified reactive species

Nicole Lund,Miroslav P Milev,Raymond Wong,Tharmila Sanmuganantham,Kathryn Woolaway,Benoit Chabot,Sherif Abou Elela,Andrew J Mouland,Alan Cochrane

Retrovirology 8:47 PubMed21682887

2011

Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy.

Applications

WB

Species

Human

Raymond Wong,Ahalya Balachandran,Annie Yq Mao,Wendy Dobson,Scott Gray-Owen,Alan Cochrane
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com